Glaceum

About:

Glaceum is a company that develops drugs to treat metabolic diseases of aging by restoring mitochondrial function.

Website: https://www.glaceum.com

Top Investors: Neurobionet

Description:

Total Funding Amount:

2B KRW

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seongnam, Kyonggi-do, South Korea

Founded Date:

2006-01-01

Contact Email:

rapanooi(AT)glaceum.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2021-08-11

IPO Status:

Private

Industries: